This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of insulin glargine-yfgn U100 pens (3 mL) and has a ceiling value of $10,678.46. The contract is a firm fixed-price contract with a completion date of June 12, 2024. This award is associated with a larger indefinite delivery contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide insulin glargine-yfgn U100 pens. The contract has a ceiling value of $1,872.71 and a performance period through March 29, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Glargine-yfgn U100 Pen 3ML. The contract has a Ceiling Value of $1,575.60 and runs through January 28, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Insulin Glargine-yfgn U100 pens, with a ceiling value of $2,250.94 and a period of performance through January 16, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Glargine-yfgn U100 pens, with a ceiling value of $6,131.75 and a completion date of January 14, 2025. The contract is not designated as a set-aside and was awarded as a firm-fixed-price delivery order. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Glargine-yfgn U100 Pen 3ML, a type of insulin medication, with a ceiling value of $60,512.43 and a completion date of January 6, 2025. The contract is structured as a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Glargine-yfgn U100 Pen 3ML, a critical medical commodity, over a period ending on January 21, 2025. The contract has a firm fixed price ceiling value of $9,744.82 and is designated as a delivery order, without any set-aside requirements. AmerisourceBergen holds a significant...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of insulin glargine-yfgn U100 pens, a specialty pharmaceutical product, to support military treatment programs and facilities. The contract has a ceiling value of $7,884.18 and a performance period through March 19, 2024. Amerisourcebergen Drug Corp holds an Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,841.00, is for the supply of insulin glargine-yfgn U100 pens. The contract has a completion date of December 27, 2024 and is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a $17,179.01 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565372242 Insulin Glargine-yfgn U100 Pen 3ML. The contract has an ultimate completion date of August 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...